Novo Nordisk to Offer Ozempic for $499 Per Month
View all comments(0)
Shares of Novo Nordisk rose over 5% in premarket trading. Novo Nordisk said on Monday that it was launching a new offer for self-paying type 2 diabetes patients to access authentic Ozempic for $499 per month.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
The Week Ahead: Fed September Minutes, PepsiCo and Delta Earnings in Focus

MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes

Dell vs. Hewlett Packard Enterprise: Which AI Server Stock Is a Better Buy?

Wall Street puts a price on AI compute as miners pivot

PLTR, CRM, NOW, SNOW Comparison: Palantir Leads Growth, Salesforce's AI ARR Is Clearer






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.